⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for physiological effects of drugs

Every month we try and update this database with for physiological effects of drugs cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)NCT04964934
ER-Positive HER...
AZD9833
AZD9833 Placebo
Anastrozole
Anastrozole pla...
Letrozole
Letrozole place...
Palbociclib
Abemaciclib
Luteinizing hor...
Ribociclib
18 Years - 130 YearsAstraZeneca
A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced DiseaseNCT04711252
ER-Positive HER...
AZD9833
Anastrozole
Anastrozole pla...
AZD9833 placebo
Palbociclib
Luteinizing hor...
18 Years - 130 YearsAstraZeneca
Natural Killer Cell (CYNK-001) Infusions in Adults With AMLNCT04310592
Leukemia
Leukemia, Myelo...
Leukemia, Myelo...
Neoplasms by Hi...
Neoplasms
Immunosuppressi...
Immunologic Fac...
Physiological E...
Alkylating Agen...
Antimetabolites...
Antiviral Agent...
Analgesics, Non...
Anti-infective ...
Analgesics
Peripheral Nerv...
Hematologic Dis...
Hematologic Neo...
Leukemia in Rem...
Relapsed Adult ...
Refractory AML
CYNK-001
18 Years - 80 YearsCelularity Incorporated
Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic CaNCT01555489
Stage IV Pancre...
Ascorbic Acid
18 Years - Thomas Jefferson University
Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to PlaceboNCT01512173
Infantile Heman...
propranolol gel
Placebo
35 Days - 150 DaysPierre Fabre Dermatology
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple MyelomaNCT04309084
Multiple Myelom...
Neoplasm, Plasm...
Neoplasms by Hi...
Neoplasms
Hemostatic Diso...
Vascular Diseas...
Cardiovascular ...
Paraproteinemia...
Blood Protein D...
Hematologic Dis...
Hemorrhagic Dis...
Lymphoprolifera...
Immunoprolifera...
Immune System D...
Antineoplastic ...
Analgesics, Non...
Analgesics
Sensory System ...
Peripheral Nerv...
Physiological E...
CYNK-001
18 Years - 75 YearsCelularity Incorporated
Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell CarcinomaNCT01339975
Carcinoma
Carcinoma Renal...
Kidney Neoplasm...
Kidney Diseases
Chemokines
Biological samp...
Biological samp...
18 Years - University Hospital, Bordeaux
Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer TumorsNCT01204801
Breast Cancer
Focused Microwa...
Chemotherapy (c...
18 Years - Medifocus, Inc.
Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to PlaceboNCT01512173
Infantile Heman...
propranolol gel
Placebo
35 Days - 150 DaysPierre Fabre Dermatology
Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent GlioblastomaNCT02010606
Glioblastoma
Glioblastoma Mu...
Glioma
Astrocytoma
Brain Tumor
Dendritic cell ...
Dendritic cell ...
18 Years - Cedars-Sinai Medical Center
New Individualized Therapy Trial for Metastatic Colorectal CancerNCT00867334
Colorectal Neop...
Colorectal Canc...
Imatinib mesyla...
Standard-of-car...
18 Years - Inova Health Care Services
ADC-1013 First-in-Human StudyNCT02379741
Neoplasms
Solid Tumors
ADC-1013
18 Years - Alligator Bioscience AB
Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent GlioblastomaNCT02010606
Glioblastoma
Glioblastoma Mu...
Glioma
Astrocytoma
Brain Tumor
Dendritic cell ...
Dendritic cell ...
18 Years - Cedars-Sinai Medical Center
A Phase III Trial of Recombinant Human Apo-2 Ligand for InjectionNCT03083743
Non-small-cell ...
Recombinant hum...
Placebo
18 Years - 75 YearsShanghai Gebaide Biotechnology Co., Ltd.
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)NCT01009593
Hepatocellular ...
Hepatocellular ...
Carcinoma, Hepa...
Liver Diseases
Neoplasms by Hi...
Digestive Syste...
Carcinoma
Liver Neoplasms
Neoplasms
Neoplasms by Si...
Digestive Syste...
Adenocarcinoma
Neoplasms, Glan...
ABT-869
Sorafenib
18 Years - Abbott
Automated Telephone Monitoring for Symptom ManagementNCT00799084
Carcinoma
Nurse
AVR
21 Years - Michigan State University
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisNCT06001385
Acute Lymphobla...
Acute Myeloid L...
Acute Leukemia
Myelodysplastic...
Chronic Myeloid...
Chronic Lymphoc...
Myeloproliferat...
Lymphoma
Chronic Myelomo...
Pro-Lymphocytic...
Myelofibrosis
Busulfan
Fludarabine
PBSC Hematopoie...
Post-Transplant...
Mesna
Tacrolimus
Mycophenolate M...
Patient Reporte...
Melphalan
Total-body irra...
Cyclophosphamid...
18 Years - Center for International Blood and Marrow Transplant Research
Pain and Fatigue StudyNCT00006253
Carcinoma
Nurse
Non-nurse coach
21 Years - Michigan State University
Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for CancerNCT02385617
Esophageal Neop...
Stomach Neoplas...
Weight Loss
Malnutrition
Octreotide
Placebo
18 Years - 100 YearsSt. James's Hospital, Ireland
Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell CarcinomaNCT01339975
Carcinoma
Carcinoma Renal...
Kidney Neoplasm...
Kidney Diseases
Chemokines
Biological samp...
Biological samp...
18 Years - University Hospital, Bordeaux
First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid TumorsNCT05768139
Breast Cancer
Gynecologic Can...
HNSCC
Solid Tumors, A...
STX-478
Fulvestrant
18 Years - Scorpion Therapeutics, Inc.
Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic CaNCT01555489
Stage IV Pancre...
Ascorbic Acid
18 Years - Thomas Jefferson University
Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast CancerNCT05242874
Chemotherapy-in...
Fosaprepitant ,...
Fosaprepitant ,...
18 Years - 70 YearsHenan Cancer Hospital
Vascular Function and Uterine FibroidsNCT02123069
Leiomyoma
Brachial artery...
Acetylcholine
Nitroprusside
Norepinephrine
Nitroprusside a...
25 Years - 50 YearsMayo Clinic
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)NCT01009593
Hepatocellular ...
Hepatocellular ...
Carcinoma, Hepa...
Liver Diseases
Neoplasms by Hi...
Digestive Syste...
Carcinoma
Liver Neoplasms
Neoplasms
Neoplasms by Si...
Digestive Syste...
Adenocarcinoma
Neoplasms, Glan...
ABT-869
Sorafenib
18 Years - Abbott
Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline MutationNCT04711109
BRCA1 Mutation
Breast Cancer
Breast Diseases
Breast Neoplasm...
Breast Carcinom...
Neoplasms
Denosumab
Placebo
Quality-of-Life...
25 Years - 55 YearsAlliance for Clinical Trials in Oncology
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder CancerNCT03933826
Bladder Cancer
Cancer of the B...
Non-muscle Inva...
18 Years - University of Washington
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)NCT04964934
ER-Positive HER...
AZD9833
AZD9833 Placebo
Anastrozole
Anastrozole pla...
Letrozole
Letrozole place...
Palbociclib
Abemaciclib
Luteinizing hor...
Ribociclib
18 Years - 130 YearsAstraZeneca
Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer TumorsNCT01204801
Breast Cancer
Focused Microwa...
Chemotherapy (c...
18 Years - Medifocus, Inc.
Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)NCT00773747
Multiple Myelom...
Vorinostat
bortezomib
placebo to vori...
18 Years - Merck Sharp & Dohme LLC
Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBMNCT04489420
Astrocytoma, Gr...
Giant Cell Glio...
Glioblastoma Mu...
Cyclophosphamid...
Immunosuppressi...
Immunologic Fac...
Physiological E...
Molecular Mecha...
Antiviral Agent...
Anti-infective ...
Analgesics, Non...
Analgesics
Sensory System ...
Peripheral Nerv...
CYNK001-IV
CYNK001-IT
18 Years - Celularity Incorporated
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal CancerNCT00838578
Colorectal Canc...
KRN330
Irinotecan
18 Years - Kyowa Kirin Co., Ltd.
Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio ImmunotherapyNCT01384253
Breast Neoplasm...
Peritoneal Neop...
Ovarian Neoplas...
Pancreatic Neop...
Stomach Neoplas...
²¹²Pb-TCMC-Tras...
trastuzumab
19 Years - Orano Med LLC
SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell LymphomaNCT00365274
Anaplastic Larg...
Cyclophosphamid...
Doxorubicin hyd...
vincristine sul...
prednisone
SGN-30
18 Years - National Cancer Institute (NCI)
Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin DNCT01166763
Breast Cancer
vitamin D3
- 55 YearsUniversity of Kansas Medical Center
Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CANCT01550510
Stage IV Colore...
Ascorbic Acid
Irinotecan
18 Years - Thomas Jefferson University
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation CyclophosphamideNCT04904588
Acute Lymphobla...
Acute Myelogeno...
Mixed Phenotype...
Acute Leukemia
Myelodysplastic...
Chronic Myeloge...
Chronic Lymphoc...
Lymphoma
Busulfan
Busulfan
Fludarabine
Total-body irra...
Cyclophosphamid...
Melphalan
PBSC Hematopoie...
Bone Marrow Hem...
Post-transplant...
Mesna
Tacrolimus
Mycophenolate M...
Patient-Reporte...
1 Year - Center for International Blood and Marrow Transplant Research
Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell CarcinomaNCT01339975
Carcinoma
Carcinoma Renal...
Kidney Neoplasm...
Kidney Diseases
Chemokines
Biological samp...
Biological samp...
18 Years - University Hospital, Bordeaux
A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin LymphomaNCT01990534
Hodgkin Lymphom...
Brentuximab Ved...
18 Years - Takeda
New Individualized Therapy Trial for Metastatic Colorectal CancerNCT00867334
Colorectal Neop...
Colorectal Canc...
Imatinib mesyla...
Standard-of-car...
18 Years - Inova Health Care Services
Natural Killer Cell (CYNK-001) Infusions in Adults With AMLNCT04310592
Leukemia
Leukemia, Myelo...
Leukemia, Myelo...
Neoplasms by Hi...
Neoplasms
Immunosuppressi...
Immunologic Fac...
Physiological E...
Alkylating Agen...
Antimetabolites...
Antiviral Agent...
Analgesics, Non...
Anti-infective ...
Analgesics
Peripheral Nerv...
Hematologic Dis...
Hematologic Neo...
Leukemia in Rem...
Relapsed Adult ...
Refractory AML
CYNK-001
18 Years - 80 YearsCelularity Incorporated
Intra-Peritoneal Local Anaesthesia After Cytoreductive SurgeryNCT02256228
Pain
Ropivacaine
Saline
18 Years - 74 YearsGöteborg University
An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker AnalysisNCT01743560
Oestrogen Recep...
RAD001
Exemestane
18 Years - Novartis
A Phase III Trial of Recombinant Human Apo-2 Ligand for InjectionNCT03083743
Non-small-cell ...
Recombinant hum...
Placebo
18 Years - 75 YearsShanghai Gebaide Biotechnology Co., Ltd.
Study of AGEN2034 in Advanced Tumors and Cervical CancerNCT03104699
Advanced Cancer
Cervical Cancer
AGEN2034
18 Years - Agenus Inc.
A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid TumorsNCT03369223
Advanced Cancer
BMS-986249
Nivolumab
Ipilimumab
18 Years - Bristol-Myers Squibb
Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CANCT01550510
Stage IV Colore...
Ascorbic Acid
Irinotecan
18 Years - Thomas Jefferson University
Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine TumorsNCT01215578
Neuroendocrine ...
Pancreatic Neop...
Advanced Diseas...
Sunitinib
Sutent
18 Years - Assistance Publique - Hôpitaux de Paris
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: